{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:20:16Z","timestamp":1719879616553},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"DOI":"10.7759\/cureus.63570","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T11:04:51Z","timestamp":1719831891000},"source":"Crossref","is-referenced-by-count":0,"title":["Carbapenem Versus Non-carbapenem Therapy in Hematology Patients: Extended-Spectrum Beta-Lactamase Positive Enterobacteriaceae Colonization Impact"],"prefix":"10.7759","author":[{"given":"Hande","family":"Berk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nefise","family":"Oztoprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Kizilates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdal","family":"Kurto\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Seremet Keskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch D","year":"2013","unstructured":"Averbuch D, Orasch C, Cordonnier C, et al.. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013, 98:1826-35. 10.3324\/haematol.2013.091025","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.02.002","article-title":"Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies","volume":"58","author":"Trecarichi EM","year":"2009","unstructured":"Trecarichi EM, Tumbarello M, Spanu T, et al.. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect. 2009, 58:299-307. 10.1016\/j.jinf.2009.02.002","journal-title":"J Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp411","article-title":"Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome","volume":"65","author":"Gudiol C","year":"2010","unstructured":"Gudiol C, Calatayud L, Garcia-Vidal C, et al.. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother. 2010, 65:333-41. 10.1093\/jac\/dkp411","journal-title":"J Antimicrob Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq494","article-title":"Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes","volume":"66","author":"Gudiol C","year":"2011","unstructured":"Gudiol C, Tubau F, Calatayud L, et al.. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011, 66:657-63. 10.1093\/jac\/dkq494","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.01.078","article-title":"Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant","volume":"13","author":"Weinstock DM","year":"2007","unstructured":"Weinstock DM, Conlon M, Iovino C, et al.. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2007, 13:615-21. 10.1016\/j.bbmt.2007.01.078","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0260-3","article-title":"Value of pretransplant screening for colonization of Pseudomonas aeruginosa in reduced-intensity umbilical cord blood transplantation for adult patients","volume":"86","author":"Narimatsu H","year":"2007","unstructured":"Narimatsu H, Kami M, Miyakoshi S, et al.. Value of pretransplant screening for colonization of Pseudomonas aeruginosa in reduced-intensity umbilical cord blood transplantation for adult patients. Ann Hematol. 2007, 86:449-51. 10.1007\/s00277-007-0260-3","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.3.435","article-title":"Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia","volume":"30","author":"Wingard JR","year":"1986","unstructured":"Wingard JR, Dick J, Charache P, Saral R. Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia. Antimicrob Agents Chemother. 1986, 30:435-9. 10.1128\/AAC.30.3.435","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twenty-second informational supplement. (2012). Accessed: October 2, 2012: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091330","article-title":"Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)","volume":"98","author":"Averbuch D","year":"2013","unstructured":"Averbuch D, Cordonnier C, Livermore DM, et al.. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica. 2013, 98:1836-47. 10.3324\/haematol.2013.091330","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2013.875515","article-title":"Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - review of the literature from a clinical perspective","volume":"42","author":"Biehl LM","year":"2016","unstructured":"Biehl LM, Schmidt-Hieber M, Liss B, Cornely OA, Vehreschild MJ. Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - review of the literature from a clinical perspective. Crit Rev Microbiol. 2016, 42:1-16. 10.3109\/1040841X.2013.875515","journal-title":"Crit Rev Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2014.04.060","article-title":"Outcomes of fecal carriage of extended-spectrum \u03b2-lactamase after transrectal ultrasound-guided biopsy of the prostate","volume":"84","author":"Tukenmez Tigen E","year":"2014","unstructured":"Tukenmez Tigen E, Tandogdu Z, Ergonul O, et al.. Outcomes of fecal carriage of extended-spectrum \u03b2-lactamase after transrectal ultrasound-guided biopsy of the prostate. Urology. 2014, 84:1008-15. 10.1016\/j.urology.2014.04.060","journal-title":"Urology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-1093-x","article-title":"Risk factors for, and clinical relevance of, faecal extended-spectrum \u03b2-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies","volume":"30","author":"Arnan M","year":"2011","unstructured":"Arnan M, Gudiol C, Calatayud L, et al.. Risk factors for, and clinical relevance of, faecal extended-spectrum \u03b2-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis. 2011, 30:355-60. 10.1007\/s10096-010-1093-x","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00367-08","article-title":"Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer","volume":"52","author":"Calatayud L","year":"2008","unstructured":"Calatayud L, Arnan M, Li\u00f1ares J, et al.. Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer. Antimicrob Agents Chemother. 2008, 52:4187-90. 10.1128\/AAC.00367-08","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients","volume":"20 Suppl 1","author":"Tacconelli E","year":"2014","unstructured":"Tacconelli E, Cataldo MA, Dancer SJ, et al.. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014, 20 Suppl 1:1-55. 10.1111\/1469-0691.12427","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3225-8","article-title":"Duration of colonization with antimicrobial-resistant bacteria after ICU discharge","volume":"40","author":"Haverkate MR","year":"2014","unstructured":"Haverkate MR, Derde LP, Brun-Buisson C, Bonten MJ, Bootsma MC. Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med. 2014, 40:564-71. 10.1007\/s00134-014-3225-8","journal-title":"Intensive Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2012.05.015","article-title":"Duration of colonization by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae after hospital discharge","volume":"41","author":"Birgand G","year":"2013","unstructured":"Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC. Duration of colonization by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae after hospital discharge. Am J Infect Control. 2013, 41:443-7. 10.1016\/j.ajic.2012.05.015","journal-title":"Am J Infect Control"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2007.10.006","article-title":"Management of multidrug-resistant organisms in health care settings, 2006","volume":"35","author":"Siegel JD","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007, 35:S165-93. 10.1016\/j.ajic.2007.10.006","journal-title":"Am J Infect Control"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2675-0","article-title":"Clinical impact and risk factors for colonization with extended-spectrum \u03b2-lactamase-producing bacteria in the intensive care unit","volume":"38","author":"Razazi K","year":"2012","unstructured":"Razazi K, Derde LP, Verachten M, Legrand P, Lesprit P, Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum \u03b2-lactamase-producing bacteria in the intensive care unit. Intensive Care Med. 2012, 38:1769-78. 10.1007\/s00134-012-2675-0","journal-title":"Intensive Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.018085-0","article-title":"Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience","volume":"59","author":"Azim A","year":"2010","unstructured":"Azim A, Dwivedi M, Rao PB, et al.. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience. J Med Microbiol. 2010, 59:955-60. 10.1099\/jmm.0.018085-0","journal-title":"J Med Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2323\/jgam.52.169","article-title":"Extended spectrum beta-lactamase producing Enterobacteriaceae in Lebanese ICU patients: epidemiology and patterns of resistance","volume":"52","author":"Daoud Z","year":"2006","unstructured":"Daoud Z, Moubareck C, Hakime N, Doucet-Populaire F. Extended spectrum beta-lactamase producing Enterobacteriaceae in Lebanese ICU patients: epidemiology and patterns of resistance. J Gen Appl Microbiol. 2006, 52:169-78. 10.2323\/jgam.52.169","journal-title":"J Gen Appl Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-012-0269-y","article-title":"Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies","volume":"40","author":"Liss BJ","year":"2012","unstructured":"Liss BJ, Vehreschild JJ, Cornely OA, et al.. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2012, 40:613-9. 10.1007\/s15010-012-0269-y","journal-title":"Infection"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1086\/521260","article-title":"Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia","volume":"45","author":"Reddy P","year":"2007","unstructured":"Reddy P, Malczynski M, Obias A, et al.. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis. 2007, 45:846-52. 10.1086\/521260","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2015.10.015","article-title":"Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum \u03b2-lactamase-producing Escherichia coli causing bacteremia","volume":"84","author":"Cha MK","year":"2016","unstructured":"Cha MK, Kang CI, Kim SH, et al.. Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum \u03b2-lactamase-producing Escherichia coli causing bacteremia. Diagn Microbiol Infect Dis. 2016, 84:102-4. 10.1016\/j.diagmicrobio.2015.10.015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.04.012","article-title":"Effect of plasmids harbouring blaCTX-M on the virulence and fitness of Escherichia coli ST131 isolates","volume":"46","author":"Shin J","year":"2015","unstructured":"Shin J, Ko KS. Effect of plasmids harbouring blaCTX-M on the virulence and fitness of Escherichia coli ST131 isolates. Int J Antimicrob Agents. 2015, 46:214-8. 10.1016\/j.ijantimicag.2015.04.012","journal-title":"Int J Antimicrob Agents"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Tamma PD","year":"2015","unstructured":"Tamma PD, Han JH, Rock C, et al.. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia. Clin Infect Dis. 2015, 60:1319-25. 10.1093\/cid\/civ003","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyq046","article-title":"Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital","volume":"40","author":"Oztoprak N","year":"2010","unstructured":"Oztoprak N, Piskin N, Aydemir H, et al.. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital. Jpn J Clin Oncol. 2010, 40:761-7. 10.1093\/jjco\/hyq046","journal-title":"Jpn J Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005197.pub3","article-title":"Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams","volume":"2010","author":"Paul M","year":"2010","unstructured":"Paul M, Yahav D, Bivas A, Fraser A, Leibovici L. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Cochrane Database Syst Rev. 2010, 2010:CD005197. 10.1002\/14651858.CD005197.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref28","article-title":"Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital","volume":"53","author":"Poon LM","year":"2012","unstructured":"Poon LM, Jin J, Chee YL, et al.. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital. Singapore Med J. 2012, 53:720-5.","journal-title":"Singapore Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/258889-carbapenem-versus-non-carbapenem-therapy-in-hematology-patients-extended-spectrum-beta-lactamase-positive-enterobacteriaceae-colonization-impact","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T11:04:56Z","timestamp":1719831896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/258889-carbapenem-versus-non-carbapenem-therapy-in-hematology-patients-extended-spectrum-beta-lactamase-positive-enterobacteriaceae-colonization-impact"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.63570","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}